Lack of benefits of mammalian target of rapamycin inhibitor in patients transplanted for hepatocellular carcinoma: Is this the end of the story?
Department of Surgery, Universitätsklinikum Regensburg, Regensburg, Germany.
Edward K
EK
Geissler
Department of Surgery, Universitätsklinikum Regensburg, Regensburg, Germany.
Andreas A
AA
Schnitzbauer
Department of Surgery, Universitätsklinikum Regensburg, Regensburg, Germany.
Hans J
HJ
Schlitt
D000818:Animals; D006528:Carcinoma, Hepatocellular; D006801:Humans; D008113:Liver Neoplasms; D016031:Liver Transplantation; D020123:Sirolimus; D058570:TOR Serine-Threonine Kinases
D058570:TOR Serine-Threonine Kinases; D020123:Sirolimus